Literature DB >> 17606685

Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.

Amera Gibreel1, Nicole M Wetsch, Diane E Taylor.   

Abstract

We investigated the involvement of the CmeABC efflux pump in acquired resistance of Campylobacter jejuni to macrolides and tetracycline. Inactivation of the cmeB gene had no effect on macrolide resistance when all copies of the target gene carried an A2074C mutation. In contrast, the CmeABC pump significantly contributed to macrolide resistance when two or three copies of the 23S rRNA had an A2075G transition. Inactivation of the cmeB gene led to restoration of tetracycline susceptibility in the isolates examined. Complete susceptibility to tetracycline or macrolides, however, was not restored when phenylalanine-arginine beta-naphthylamide was used. These data confirm contribution of the CmeABC efflux pump to acquired resistance of Campylobacter jejuni to tetracycline and macrolides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17606685      PMCID: PMC2043232          DOI: 10.1128/AAC.01592-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump.

Authors:  Naidan Luo; Orhan Sahin; Jun Lin; Linda O Michel; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

2.  Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  Cédric Cagliero; Christian Mouline; Axel Cloeckaert; Sophie Payot
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

3.  Rapid detection of mutations associated with resistance to erythromycin in Campylobacter jejuni/coli by PCR and line probe assay.

Authors:  H Niwa; T Chuma; K Okamoto; K Itoh
Journal:  Int J Antimicrob Agents       Date:  2001-10       Impact factor: 5.283

4.  Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump.

Authors:  Lilian Pumbwe; Laura J V Piddock
Journal:  FEMS Microbiol Lett       Date:  2002-01-10       Impact factor: 2.742

5.  PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp.

Authors:  Sylvie Vacher; Armelle Ménard; Elisabeth Bernard; Francis Mégraud
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 6.  Campylobacter jejuni Infections: update on emerging issues and trends.

Authors:  B M Allos
Journal:  Clin Infect Dis       Date:  2001-03-28       Impact factor: 9.079

7.  Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance.

Authors:  Amera Gibreel; Dobryan M Tracz; Lisa Nonaka; Trinh M Ngo; Sean R Connell; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides.

Authors:  Laurent Mamelli; Jean-Pierre Amoros; Jean-Marie Pagès; Jean-Michel Bolla
Journal:  Int J Antimicrob Agents       Date:  2003-09       Impact factor: 5.283

9.  Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli.

Authors:  Sophie Payot; Laetitia Avrain; Catherine Magras; Karine Praud; Axel Cloeckaert; Elisabeth Chaslus-Dancla
Journal:  Int J Antimicrob Agents       Date:  2004-05       Impact factor: 5.283

10.  CmeABC functions as a multidrug efflux system in Campylobacter jejuni.

Authors:  Jun Lin; Linda Overbye Michel; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

View more
  23 in total

Review 1.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

2.  Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni.

Authors:  Haihong Hao; Zonghui Yuan; Zhangqi Shen; Jing Han; Orhan Sahin; Peng Liu; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

3.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

4.  Campylobacter jejuni Antimicrobial Resistance Profiles and Mechanisms Determined Using a Raman Spectroscopy-Based Metabolomic Approach.

Authors:  Luyao Ma; Lei Chen; Keng C Chou; Xiaonan Lu
Journal:  Appl Environ Microbiol       Date:  2021-05-26       Impact factor: 4.792

Review 5.  The Current State of Macrolide Resistance in Campylobacter spp.: Trends and Impacts of Resistance Mechanisms.

Authors:  Hannah Bolinger; Sophia Kathariou
Journal:  Appl Environ Microbiol       Date:  2017-05-31       Impact factor: 4.792

6.  Withdrawal of antibiotic growth promoters in China and its impact on the foodborne pathogen Campylobacter coli of swine origin.

Authors:  Renqiao Wen; Chao Li; Mengyu Zhao; Hongning Wang; Yizhi Tang
Journal:  Front Microbiol       Date:  2022-09-08       Impact factor: 6.064

Review 7.  Antibiotic resistance in Campylobacter: emergence, transmission and persistence.

Authors:  Taradon Luangtongkum; Byeonghwa Jeon; Jing Han; Paul Plummer; Catherine M Logue; Qijing Zhang
Journal:  Future Microbiol       Date:  2009-03       Impact factor: 3.165

8.  Significant contribution of the CmeABC Efflux pump in high-level resistance to ciprofloxacin and tetracycline in Campylobacter jejuni and Campylobacter coli clinical isolates.

Authors:  Saeed Sharifi; Bita Bakhshi; Shahin Najar-Peerayeh
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-05-20       Impact factor: 3.944

9.  Genetic Basis and Functional Consequences of Differential Expression of the CmeABC Efflux Pump in Campylobacter jejuni Isolates.

Authors:  Tara Grinnage-Pulley; Qijing Zhang
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 10.  Resistance mechanisms in Campylobacter jejuni.

Authors:  Nicole M Iovine
Journal:  Virulence       Date:  2013-02-13       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.